Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication.

Nakao T, Radua J, Rubia K, Mataix-Cols D.

Am J Psychiatry. 2011 Nov;168(11):1154-63. doi: 10.1176/appi.ajp.2011.11020281. Epub 2011 Aug 24.

PMID:
21865529
2.

Brain abnormalities in attention-deficit hyperactivity disorder: a review.

Rubia K, Alegría AA, Brinson H.

Rev Neurol. 2014 Feb 24;58 Suppl 1:S3-16. Review. English, Spanish.

PMID:
25252664
3.

Cortical and Subcortical Gray Matter Volume in Youths With Conduct Problems: A Meta-analysis.

Rogers JC, De Brito SA.

JAMA Psychiatry. 2016 Jan;73(1):64-72. doi: 10.1001/jamapsychiatry.2015.2423. Review.

PMID:
26650724
4.

Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects.

Frodl T, Skokauskas N.

Acta Psychiatr Scand. 2012 Feb;125(2):114-26. doi: 10.1111/j.1600-0447.2011.01786.x. Epub 2011 Nov 28. Review.

PMID:
22118249
5.

Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.

Rubia K, Alegria AA, Cubillo AI, Smith AB, Brammer MJ, Radua J.

Biol Psychiatry. 2014 Oct 15;76(8):616-28. doi: 10.1016/j.biopsych.2013.10.016. Epub 2013 Oct 24. Review.

6.

MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder.

Schweren LJ, de Zeeuw P, Durston S.

Eur Neuropsychopharmacol. 2013 Oct;23(10):1151-64. doi: 10.1016/j.euroneuro.2012.10.014. Epub 2012 Nov 17. Review.

PMID:
23165220
7.

Gray matter abnormalities as brain structural vulnerability factors for bipolar disorder: A review of neuroimaging studies of individuals at high genetic risk for bipolar disorder.

Nery FG, Monkul ES, Lafer B.

Aust N Z J Psychiatry. 2013 Dec;47(12):1124-35. doi: 10.1177/0004867413496482. Epub 2013 Jul 17. Review.

PMID:
23864160
8.

Stimulant drug effects on attention deficit/hyperactivity disorder: a review of the effects of age and sex of patients.

Cornforth C, Sonuga-Barke E, Coghill D.

Curr Pharm Des. 2010;16(22):2424-33. Review.

PMID:
20513225
9.
10.

Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.

Poulton A.

Expert Rev Neurother. 2006 Apr;6(4):551-61. Review.

PMID:
16623654
11.

Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience.

Ersche KD, Williams GB, Robbins TW, Bullmore ET.

Curr Opin Neurobiol. 2013 Aug;23(4):615-24. doi: 10.1016/j.conb.2013.02.017. Epub 2013 Mar 20. Review.

12.

Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Otasowie J, Castells X, Ehimare UP, Smith CH.

Cochrane Database Syst Rev. 2014 Sep 19;(9):CD006997. doi: 10.1002/14651858.CD006997.pub2. Review.

PMID:
25238582
13.

Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.

Martinez-Raga J, Knecht C, Szerman N, Martinez MI.

CNS Drugs. 2013 Jan;27(1):15-30. doi: 10.1007/s40263-012-0019-9. Review.

PMID:
23160939
14.

[Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].

Emond V, Joyal C, Poissant H.

Encephale. 2009 Apr;35(2):107-14. doi: 10.1016/j.encep.2008.01.005. Epub 2008 Jul 7. Review. French.

PMID:
19393378
15.

Family therapy for attention-deficit disorder or attention-deficit/hyperactivity disorder in children and adolescents.

Bjornstad G, Montgomery P.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD005042. Review.

PMID:
15846741
16.

Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities.

Thomson A, Maltezos S, Paliokosta E, Xenitidis K.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007009. doi: 10.1002/14651858.CD007009.pub2. Review.

PMID:
19160313
17.

Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

Epstein T, Patsopoulos NA, Weiser M.

Cochrane Database Syst Rev. 2014 Sep 18;(9):CD005041. doi: 10.1002/14651858.CD005041.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;(5):CD005041.

PMID:
25230710
18.

Imaging genetics in attention-deficit/hyperactivity disorder and related neurodevelopmental domains: state of the art.

Vilor-Tejedor N, Cáceres A, Pujol J, Sunyer J, González JR.

Brain Imaging Behav. 2016 Dec 15. [Epub ahead of print] Review.

PMID:
27981420
19.

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data.

Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME, Toro R, Jahanshad N, Schumann G, Franke B, Wright MJ, Martin NG, Agartz I, Alda M, Alhusaini S, Almasy L, Almeida J, Alpert K, Andreasen NC, Andreassen OA, Apostolova LG, Appel K, Armstrong NJ, Aribisala B, Bastin ME, Bauer M, Bearden CE, Bergmann O, Binder EB, Blangero J, Bockholt HJ, Bøen E, Bois C, Boomsma DI, Booth T, Bowman IJ, Bralten J, Brouwer RM, Brunner HG, Brohawn DG, Buckner RL, Buitelaar J, Bulayeva K, Bustillo JR, Calhoun VD, Cannon DM, Cantor RM, Carless MA, Caseras X, Cavalleri GL, Chakravarty MM, Chang KD, Ching CR, Christoforou A, Cichon S, Clark VP, Conrod P, Coppola G, Crespo-Facorro B, Curran JE, Czisch M, Deary IJ, de Geus EJ, den Braber A, Delvecchio G, Depondt C, de Haan L, de Zubicaray GI, Dima D, Dimitrova R, Djurovic S, Dong H, Donohoe G, Duggirala R, Dyer TD, Ehrlich S, Ekman CJ, Elvsåshagen T, Emsell L, Erk S, Espeseth T, Fagerness J, Fears S, Fedko I, Fernández G, Fisher SE, Foroud T, Fox PT, Francks C, Frangou S, Frey EM, Frodl T, Frouin V, Garavan H, Giddaluru S, Glahn DC, Godlewska B, Goldstein RZ, Gollub RL, Grabe HJ, Grimm O, Gruber O, Guadalupe T, Gur RE, Gur RC, Göring HH, Hagenaars S, Hajek T, Hall GB, Hall J, Hardy J, Hartman CA, Hass J, Hatton SN, Haukvik UK, Hegenscheid K, Heinz A, Hickie IB, Ho BC, Hoehn D, Hoekstra PJ, Hollinshead M, Holmes AJ, Homuth G, Hoogman M, Hong LE, Hosten N, Hottenga JJ, Hulshoff Pol HE, Hwang KS, Jack CR Jr, Jenkinson M, Johnston C, Jönsson EG, Kahn RS, Kasperaviciute D, Kelly S, Kim S, Kochunov P, Koenders L, Krämer B, Kwok JB, Lagopoulos J, Laje G, Landen M, Landman BA, Lauriello J, Lawrie SM, Lee PH, Le Hellard S, Lemaître H, Leonardo CD, Li CS, Liberg B, Liewald DC, Liu X, Lopez LM, Loth E, Lourdusamy A, Luciano M, Macciardi F, Machielsen MW, Macqueen GM, Malt UF, Mandl R, Manoach DS, Martinot JL, Matarin M, Mather KA, Mattheisen M, Mattingsdal M, Meyer-Lindenberg A, McDonald C, McIntosh AM, McMahon FJ, McMahon KL, Meisenzahl E, Melle I, Milaneschi Y, Mohnke S, Montgomery GW, Morris DW, Moses EK, Mueller BA, Muñoz Maniega S, Mühleisen TW, Müller-Myhsok B, Mwangi B, Nauck M, Nho K, Nichols TE, Nilsson LG, Nugent AC, Nyberg L, Olvera RL, Oosterlaan J, Ophoff RA, Pandolfo M, Papalampropoulou-Tsiridou M, Papmeyer M, Paus T, Pausova Z, Pearlson GD, Penninx BW, Peterson CP, Pfennig A, Phillips M, Pike GB, Poline JB, Potkin SG, Pütz B, Ramasamy A, Rasmussen J, Rietschel M, Rijpkema M, Risacher SL, Roffman JL, Roiz-Santiañez R, Romanczuk-Seiferth N, Rose EJ, Royle NA, Rujescu D, Ryten M, Sachdev PS, Salami A, Satterthwaite TD, Savitz J, Saykin AJ, Scanlon C, Schmaal L, Schnack HG, Schork AJ, Schulz SC, Schür R, Seidman L, Shen L, Shoemaker JM, Simmons A, Sisodiya SM, Smith C, Smoller JW, Soares JC, Sponheim SR, Sprooten E, Starr JM, Steen VM, Strakowski S, Strike L, Sussmann J, Sämann PG, Teumer A, Toga AW, Tordesillas-Gutierrez D, Trabzuni D, Trost S, Turner J, Van den Heuvel M, van der Wee NJ, van Eijk K, van Erp TG, van Haren NE, van 't Ent D, van Tol MJ, Valdés Hernández MC, Veltman DJ, Versace A, Völzke H, Walker R, Walter H, Wang L, Wardlaw JM, Weale ME, Weiner MW, Wen W, Westlye LT, Whalley HC, Whelan CD, White T, Winkler AM, Wittfeld K, Woldehawariat G, Wolf C, Zilles D, Zwiers MP, Thalamuthu A, Schofield PR, Freimer NB, Lawrence NS, Drevets W; Alzheimer’s Disease Neuroimaging Initiative, EPIGEN Consortium, IMAGEN Consortium, Saguenay Youth Study (SYS) Group..

Brain Imaging Behav. 2014 Jun;8(2):153-82. doi: 10.1007/s11682-013-9269-5. Review.

Supplemental Content

Support Center